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was considered as efﬁcient (a=10% b=10%)), the secondary criteria
were: the results at 24 months for arthroscopy, histology, MRI, and the
evaluation of the surgical technique.
Treatment: Biopsy of 200 to 300mg of cartilage from a non bearing
zone of the knee, cellular expansion and incubation in an agarose
and alginate hydrogel with manufacturing of 10, 14 or 18mm diameter
implants distributed in the lesion.
Results: 20 patients have been included, 17 have been implanted, (a
chondrocalcinosis, a culture failure, a ﬁbrocartilage reconstruction have
not been implanted). Patients characteristics: Average age: 30 years old,
12 Men/5 Women, 10 OD, Average IKDC initial score: 37, Average lesions’
surface 3 cm2. Mean criterion: IKDC at 24 months: 77.8 (p 3 cm2, and
almost signiﬁcant for OD and grade 4 lesions. MRI: 10 patients on 15 pre-
sented an identical signal/normal cartilage, for 11 patients/15 no visible
transition. Arthroscopies: 13 realized with an average ICRS score of 10 on
12. Histology: O’Driscoll Average score on 21: 16. 8 patients presented
a mostly hyaline cartilage, 3 a mixed hyaline and 1 ﬁbrocartilage. The
average surgery time was 41 minutes.
Conclusions: The cartilage graft in a CARTIPATCH® hydrogel conﬁrms
a signiﬁcant clinical improvement especially for deep and large lesions.
The use of a matrix allowing a homogeneous distribution and no cellular
leakage can explain the good histological results with over 60% of the
repaired cartilage mostly hyaline at 24 months. Two phase III studies one
versus osteochondral autografts and one versus microfracture have been
started.
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505 EFFECTS OF JOINT LAVAGE IN PATIENTS WITH
OSTEOARTHRITIS OF THE KNEE: META-ANALYSIS OF
RANDOMIZED CONTROLLED TRIALS
J. Avouac, T. Bardin, P. Richette. Hoˆpital Lariboisie`re, Paris, FRANCE
Purpose: To assess the clinical relevance of joint lavage alone or com-
bined with intraarticular steroid injection to improve pain and function in
osteoarthritis (OA) of the knee.
Methods: A systematic literature search was performed in electronic
databases (Medline, Embase and Cochrane database) up to April 2008.
References of the papers were hand searched to identify additional rele-
vant reports. There was no language restriction. All randomized controlled
trials (RCTs) performed on patients with knee OA with parallel groups
and evaluating either (1) the efﬁcacy of joint lavage alone versus placebo
or (2) joint lavage combined with steroid injection versus joint lavage
alone, were selected. Efﬁcacy was evaluated on pain intensity (pain
visual analogic scale [VAS], Western Ontario and Mac master universities
Osteoarthritis index [WOMAC] subscale for pain or pain on movement
VAS) and physical function (WOMAC function or Lequesne’s functional
index). The time point for evaluation was a priori decided and ﬁxed at three
months. Effect sizes were calculated using RevMan to compare results
across studies. We used the standardized mean difference (change from
baseline pain or function at 3 months) as our measure of effect size for
each study.
Results: From the 334 articles identiﬁed, seven RCTs (four studies
analyzed joint lavage versus placebo, and three joint lavage with steroid
injection versus joint lavage alone) were included and analyzed, i.e. a total
of 1009 patients (582 in the active group and 427 in the control group).
The median (min-max) value of the journals’ impact factor in which were
published the different trials was 5.78 (3.06−51.3) and the mean (SD)
Jadad score was 3.5 (1.5). The pooled effect sizes of joint lavage versus
placebo were not signiﬁcant for pain intensity (ES=−0.02 [−0.21, 0.17])
(ﬁgure 1) and physical function (ES=−0.16 [−0.35, 0.03]). The pooled
effect sizes of joint lavage combined with steroid injection versus joint
lavage alone were also not signiﬁcant for pain intensity (−1.24 [−1.49,
−0.99]) or physical function (ES=0.09 [−0.28, 0.45]).
Conclusions: This meta-analysis suggests that at three months (i) joint
lavage alone does not provide signiﬁcant improvement in pain or function
over placebo, (ii) combination of lavage and intraarticular steroid injection
is no more efﬁcacious than lavage alone.
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R.J. Petrella, J. DeCaria, A. Cogliano. U Western Ontario, London, ON,
CANADA
Purpose: Patients may alternate between different hyaluronic acid prod-
ucts and experience different degrees of efﬁcacy. This may be the result
of differing molecular weight needs within the synovial ﬂuid of patients
through the course of their osteoarthritis symptoms.
Methods: To compare the efﬁcacy and safety of different molecular
weight hyaluronic acid alone or in combination in patients with osteoarthri-
tis of the knee we conducted a randomized, prospective, double blind
cohort followed for 16 weeks in which patients were randomized at
baseline to receive a three intra-articular injection series with one of:
DMW (Dual molecular weight) (580–780 kDa + 1.2 to 2.0 million); LMW
(Low molecular weight) (500–730 kDa); HMW (High molecular weight)
(6 million); or saline placebo over 3 weeks. Patients completed baseline
assessment of rest and walking VAS pain (primary efﬁcacy variable),
collection of a 5-point categorical global satisfaction score and record of
adverse events.
Results: Two-hundred and twenty-ﬁve patients (age 68±8 y) were
screened and two hundred were randomized to one of the four groups.
There were no differences at baseline between groups. At 4, 12 and
16 weeks respectively, walking VAS pain was signiﬁcantly improved
in all treatment groups vs Placebo: DMW (79.6%, p< 0.001; 85.6,
p< 0.001; 89.3%, p< 0.001); LMW (73.6%, p< 0.001; 76.4, p< 0.001;
81.3%, p< 0.001) and HMW (69.1%, p< 0.001; 81.0, p< 0.001; 79.1%,
p< 0.001). Patients in the DMW group had signiﬁcantly greater improve-
ment (p< 0.007) in VAS walking pain by three weeks (following the
second injection) compared to all groups. This difference was persistent
to 16 weeks.
Conclusions: Greater improvement in patients who received the DMW
product was achieved by the second injection persistent at 16 weeks. This
suggests that patients who receive a combination of molecular weight
hyaluronic acid may have superior results.
507 HOW DO GENERAL PRACTITIONERS USE
NON-PHARMACOLOGICAL TREATMENTS IN PATIENTS WITH
PERSISTENT PAIN FROM KNEE OSTEOARTHRITIS, BASED
ON THE CLINICAL SYMPTOMS
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Mondor, Cre´teil, FRANCE, 2Hoˆpital Lyon Sud, Lyon, FRANCE
Purpose: International recommendations (EULAR) about managing knee
osteoarthritis support the concomitant use of medications and non-
pharmacological treatments. The aim of this clinical survey was to de-
termine practice patterns among general practitioners (GPs) in France
regarding non-pharmacological treatments in patients with recurrent or
persistent pain from knee osteoarthritis.
Methods: Survey among GPs. No support was received from pharma-
ceutical companies. Each GP completed a questionnaire about the ﬁrst
patient seen for recent pain exacerbation due to known knee osteoarthri-
tis. The questionnaire collected the main clinical symptoms, in order
to distinguish mechanical pain from an inﬂammatory osteoarthritis ﬂare
(nocturnal pain and synovial ﬂuid effusion), and the non-pharmacological
treatments prescribed at the end of the visit based on the clinical mani-
festations.
Results: 638 questionnaires were completed; women contributed 70% of
the patients, mean age was 66 years and mean BMI was 28 kg/m2; both
knees were affected in 50% of patients. A limp was the most common
symptom (82%); mechanical pain was noted in 75% and joint effusion in
37% of patients. Nocturnal pain with a joint effusion was present in 12%
of patients.
Overall, 30.9% of GPs recommended rest and 36.5% reducing walking.
Rest was recommended by 50% of GPs for patients with nocturnal
pain and joint effusion (ﬂare) compared to 20% for patients with neither
symptom. Although EULAR guidelines recommend regular exercise in
the absence of ﬂares, only 34.5% of GPs prescribed physical therapy.
Surprisingly, physical therapy was prescribed more often in patients with
ﬂares (46%) than without ﬂares (33.4%). Most GPs (66.6%) recom-
mended a weight-reduction diet. Using a cane was recommended by
